Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of cinnamon essential oil microcapsules with enhanced antimicrobial activity via interfacial crosslinking of OSA-modified starch nanocrystal stabilized Pickering emulsions.

International journal of biological macromolecules·2026
Same author

Generation and evaluation of an EcoHIV mouse model to study HIV-1 integration and expression.

Virology·2026
Same author

Modulating burn wound immunity and vasculature with a photo-crosslinkable glycyrrhizic acid-ginsenoside hydrogel.

Biomedical materials (Bristol, England)·2026
Same author

The epidemic and socioeconomic factors shock: a long-term dynamic analysis of equity in infectious disease healthcare in China.

International journal for equity in health·2026
Same author

Interpretable spatiotemporal traffic crash risk prediction using DMD-based graph neural networks.

Accident; analysis and prevention·2026
Same author

Genomic insights into the tmexCD-toprJ: plasmid-mediated evolution, dissemination and diversity in bacterial populations.

The Journal of antimicrobial chemotherapy·2026

Related Experiment Video

Updated: Mar 18, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

1.3K

CTC immune escape mediated by PD-L1.

Xuefei Wang1, Qiang Sun1, Qiaofei Liu1

  • 1Breast Surgery Department, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College and Hospital, China; Shanxi Provincial People's Hospital, China.

Medical Hypotheses
|July 4, 2016
PubMed
Summary

Circulating tumor cell (CTC) clusters, not individual CTCs, drive metastasis in breast cancer. PD-L1 expression on CTC clusters promotes immune evasion, leading to tumor formation and poorer patient prognosis.

More Related Videos

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.2K
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.8K

Related Experiment Videos

Last Updated: Mar 18, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

1.3K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.2K
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.8K

Area of Science:

  • Oncology
  • Immunology
  • Cancer Metastasis

Background:

  • Breast cancer is a leading cause of cancer death globally, primarily due to metastasis.
  • Circulating tumor cells (CTCs) are linked to patient prognosis, but circulating tumor cell clusters (CTCCs) exhibit significantly higher metastatic potential.
  • The underlying mechanisms of CTCC metastasis remain largely unclear.

Purpose of the Study:

  • To investigate the mechanism by which CTCCs contribute to breast cancer metastasis.
  • To explore the role of PD-L1 expression in CTCCs and their interaction with the immune microenvironment.

Main Methods:

  • Successful separation and in vitro culture of CTC clusters.
  • Analysis of PD-L1 expression on CTCs and its correlation with tumor characteristics.
  • Investigation of immune cell interactions mediated by PD-L1 on CTCs.

Main Results:

  • PD-L1 expression on CTCs correlates with tumor histological grading.
  • High PD-L1 expression was observed on the surface of CTCs.
  • PD-L1 on CTCs facilitates interactions with regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), promoting immune suppression and metastasis.

Conclusions:

  • Circulating tumor cell clusters possess a markedly higher ability for metastasis and tumor formation compared to individual CTCs.
  • PD-L1 expression on CTCs plays a crucial role in immune evasion by interacting with Tregs and MDSCs, ultimately facilitating metastatic lesion formation.